Heart Genome

Palo Alto, California, United States United States
  • Overview
  • Team
Company description

ML Software for to predict and manage risk for complex diseases. We are the first with agnostic learning model starting with Abdominal Aortic Aneurysm from as early as childhood. 

500 patients IRB proof of concept completed and validated by Cell Journal. Based on NGS and EHR data with 80%+ sensitivity.

Founded by inventor/entrepreneurs with IP from Stanford. Ready for commercialization in 6 months post funding.